Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Eliem Therapeutics Inc

(NASDAQ: ELYM)
Add to Portfolio
+0.05 (+0.65%)
as of May 31, 2024


Date Form Description HTML Word PDF Excel
May 17, 2024 PREM14A Proxy Statement - Merger or Acquistion (preliminary)  
May 17, 2024 SC 13D/A Amended Statement of Beneficial Ownership  
May 17, 2024 SC 13D/A Amended Statement of Beneficial Ownership  
May 15, 2024 10-Q Quarterly Report
May 07, 2024 SC 13G Statement of Ownership  
Apr 29, 2024 10-K/A Amended Annual Report
Apr 12, 2024 SC 13D/A Amended Statement of Beneficial Ownership  
Apr 11, 2024 DEFA14A Additional Proxy Soliciting Materials (definitive)  
Apr 11, 2024 8-K Current report filing
Mar 28, 2024 S-8 Securities Registration: Employee Benefit Plan  
Mar 28, 2024 10-K Annual Report
Mar 19, 2024 8-K Current report filing
Mar 18, 2024 SC 13D/A Amended Statement of Beneficial Ownership  
Nov 17, 2023 SC 13D/A Amended Statement of Beneficial Ownership  
Nov 14, 2023 10-Q Quarterly Report
Nov 13, 2023 SC 13D/A Amended Statement of Beneficial Ownership  
Aug 10, 2023 10-Q Quarterly Report
Jul 20, 2023 8-K Current report filing
May 19, 2023 8-K Current report filing
May 11, 2023 8-K Current report filing
May 11, 2023 10-Q Quarterly Report
Apr 10, 2023 SC 13D/A Amended Statement of Beneficial Ownership  
Apr 06, 2023 ARS Annual Report to Security Holders  
Apr 06, 2023 DEFA14A Additional Proxy Soliciting Materials (definitive)  
Apr 06, 2023 DEF 14A Proxy Statement (definitive)